AMARILLO, Texas--(BUSINESS WIRE)--Amarillo Biosciences, Inc. (OTCBB: AMAR) today announced that it had privately placed a $1,000,000 convertible preferred issue with Firebird Global Master Fund, Ltd., an affiliate of New York-based Firebird Management LLC, which manages over $3 billion.
